Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients

Prostate Cancer and Prostatic Diseases

Volumn 10, Issue 3, 2007, Pages 293-300

  Zhang, Y ^a   Forootan, S S ^a   Liu, D ^a   Barraclough, R ^a   Foster, C S ^a   Rudland, P S ^a   Ke, Y ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANTERIOR GRADIENT 2 PROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN AGR2; SECRETORY PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC CODE; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR CELL;

ADENOCARCINOMA; AGED; BLOTTING, WESTERN; CELL LINE, TUMOR; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 34548452625     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500960     Document Type: Article

References (36)

1. Tarassoff CP, Arlen PM, Gulley JL. Therapeutic vaccines for prostate cancer. Oncologist 2006; 11: 451-462.
2. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 1999; 41: 8-31.
3. Foster CS, Cornford P, Forsyth L, Djamgoz MB, Ke Y. The cellular and molecular basis of prostate cancer. BJU Int 1999; 83: 171-194.
4. Jemal A, Murray T, Ward E, Samuels A, Tiwari R, Ghafoor A et al. Cancer statistics. CA Cancer J Clin 2005; 55: 10-30.
5. Hughes C, Murphy A, Martin C, Sheils O, O'Leary J. Molecular pathology of prostate cancer. J Clin Pathol 2005; 58: 673-684.
6. Jing C, Beesley C, Foster C, Chen H, Rudland P, West D et al. Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells. Cancer Res 2001; 61: 4357-4364.
7. Jing C, El-Ghany M, Beesley C, Foster C, Rudland P, Smith P et al. Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to the tumorigenicity. J Natl Cancer Inst 2002; 94: 482-490.
8. May F, Hartung R, Breul J. The ability of the American Joint Committee on Cancer Staging System to predict progression-free survival after radical prostatectomy. BJU Int 2001; 88: 702-707.
9. Thompson DA, Weigel RJ. hAG-2, the human homologue of the Xenopus laeuis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochem Biophys Res Commun 1998; 251: 111-116.
10. Komiya T, Tanigawa Y, Hirohashi S. Cloning of the gene gob-4, which is expressed in intestinal goblet cells in mice. Biochim Biophys Acta 1999; 1444: 434-438.
11. Aberger F, Weidinger G, Grunz H, Richter K. Anterior specification of embryonic ectoderm: The role of the Xenopus cement gland-specific gene XAG-2. Mech Dev 1998; 72: 115-130.
12. Liu D, Rudland PS, Sibson DR, Platt-Higgins A, Barraclough R. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Res 2005; 65: 3796-3805.
13. Innes H, Liu D, Barraclough R, Davies M, O'Neill P, Platt-Higgins A et al. Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients. Br J Cancer 2006; 94: 1057-1065.
14. Zhang JS, Gong A, Cheville JC, Smith DI, Young CY. AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer. Genes Chromosomes Cancer 2005; 43: 249-259.
15. Cussenot O, Berthon P, Berger R, Mowszowicz I, Faille A, Hojman F et al. Immortalization of human adult normal prostatic epithelial cells by liposomes containing Large T-SV40 gene. J Urol 1991; 143: 881-886.
16. Berthon P, Cussenot O, Hopwood L, Le Duc A, Matkland N. Functional expression of SV40 in normal human prostatic epithelial and fibroblastic cells: Differentiation pattern of non-tumorigenic cell lines. Int J Oncol 1995; 6: 333-343.
17. Horoszewicz JS, Leong S, Kawinski E, Karr J, Rosenthal H, Chu T et al. INCaP model of human prostatic carcinoma. Cancer Res 1983; 43: 1809-1818.
18. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer 1978; 21: 274-281.
19. Kaighn ME, Lechner JF, Narayan KS, Jones LW. Prostate carcinoma: Tissue culture cell lines. Natl Cancer Inst Monogr 1978; 49: 17-21.
20. Ke Y, Jing C, Barraclough R, Smith P, Davies MP, Foster CS. Elevated expression of calcium-binding protein p9Ka is associated with increasing malignant characteristics of rat prostate carcinoma cells. Int J Cancer 1997; 71: 827-837.
21. Deshmukh N, Scotson J, Dodson AR, Smith PH, Ke Y, Forster CS. Differential expression of acidic and basic fibroblast growth factors in benign prostatic hyperplasia identified by immuno-histochemistry. Br J Urol 1997; 80: 869-874.
22. Forootan SS, Foster CS, Aachi VR, Adamson J, Smith PH, Lin K et al. Prognostic significance of osteopontin expression in human prostate cancer. Int J Cancer 2006; 118: 2255-2261.
23. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111: 58-64.
24. Ito K, Yamamoto T, Ohi M, Kurokawa K, Suzuki K, Yamanaka H. Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1-10 ng/ml. Urology 2003; 61 760-764.
25. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathology 1987; 8 138-140.
26. Stanbrough M, Leav I, Kwan PW, Bubley GJ, Balk SP. Prostatic intraepithelial neoplasia in mice expression an androgen receptor transgene in prostate epithelium. Proc Natl Acad Sci USA 2001; 98: 10823-10828.
27. Kuang WW, Thompson DA, Hoch RV, Weigel RJ. Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res 1998; 26: 1116-1123.
28. Fletcher GC, Patel S, Tyson K, Adam P, Schenker M, Loader J et al. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br J cancer 2003; 88: 579-585.
29. Fritzsche F, Dahl E, Pahl S, Burkhardt M, Luo J, Mayordomo E et al. Prognostic relevance of AGR2 expression in breast cancer. Clin Cancer Res 2006; 12: 1728-1734.
30. Zheng W, Rosenstiel P, Huse K, Sina C, Valentonyte R, Mah N et al. Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease. Genes Immun 2006; 7: 11-18.
31. Kristiansen G, Pilarsky C, Wissmann C, Kaiser S, Bruemmendorf T, Roepcke S. et al. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J Pathol 2005; 205: 359-376.
32. Adamson J, Morgan E, Beesley C, Mei Y, Forster C, Fujii H et al. High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity. Oncogene 2003; 22: 2739-2749.
33. Smith P, Rhodes N, Ke Y, Foster C. Sodium channel protein, expression enhances the invasiveness of rat and human prostate cancer cells. FEBS lett 1998; 423: 19-24.
34. Collette L, Burzykowski T, Schroder FH. Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials. Eur J Cancer 2006; 42: 1344-1350.
35. Freedland SJ, Partin AW. Prostate-specific antigen: Update 2006. Urology 2006; 67: 458-460.
36. Shah RB, Mehra R, Chinnaiyan A; Shen R, Ghosh D, Zhou M et al. Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program. Cancer Res 2004; 64: 9209-9216.